Organovo Holdings, Inc.
(NASDAQ : ONVO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
REGNRegeneron Pharmaceuticals, Inc. -0.99%724.652.6%$747.27m
AMGNAmgen, Inc. -0.40%230.011.4%$606.05m
BIIBBiogen, Inc. -0.81%260.141.8%$575.36m
MRNAModerna, Inc. -4.15%119.950.0%$565.43m
GILDGilead Sciences, Inc. -0.58%64.581.0%$546.92m
VRTXVertex Pharmaceuticals, Inc. -1.25%294.901.9%$424.55m
ILMNIllumina, Inc. -2.65%207.083.2%$399.95m
SNSSSunesis Pharmaceuticals, Inc. 1.99%4.100.7%$286.61m
SAVACassava Sciences, Inc. -4.39%40.490.0%$181.35m
BNTXBioNTech SE -1.60%135.330.0%$107.65m
TECHBio-Techne Corp. -4.35%295.654.5%$96.39m
BMRNBioMarin Pharmaceutical, Inc. -3.45%88.324.2%$92.61m
PRTAProthena Corp. Plc -2.66%57.0113.8%$77.10m
CRSPCRISPR Therapeutics AG -4.09%62.590.6%$75.02m
NVAXNovavax, Inc. -8.85%16.4875.6%$72.46m

Company Profile

Organovo Holdings, Inc. is engaged in the development of bioprinted human tissues that emulate human biology and disease. Its three-dimensional human tissue platform is enabled by its proprietary NovoGen Bioprinters and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company was founded on January 30, 2012 and is headquartered in San Diego, CA.